ARCUS BIOSCIENCES INC (RCUS) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:RCUS - US03969F1093 - Common Stock
21.8 USD
+0.01 (+0.05%)
21.8 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 112M -70.75% | 117M 4.46% | 258M 120.51% | 251.37M -2.57% | 132.5M -47.29% | 185.24M 39.80% | 411.72M 122.26% | 603.44M 46.57% | 812.18M 34.59% | 1.284B 58.09% | 1.695B 32.01% | 2.184B 28.85% | |
| EBITDA YoY % growth | -274M -572.41% | -332M -21.17% | -300M 9.64% | -370.451M -23.48% | -445.709M -20.32% | -373.379M 16.23% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -280M -616.61% | -340M -21.43% | -310M 8.82% | -394.745M -27.34% | -472.139M -19.61% | -408.521M 13.47% | -226.266M 44.61% | 20.542M 109.08% | 239.29M 1,064.88% | 646.96M 170.37% | 859.79M 32.90% | 1.155B 34.34% | |
| Operating Margin | -250.00% | -290.60% | -120.16% | -157.04% | -356.33% | -220.54% | -54.96% | 3.40% | 29.46% | 50.39% | 50.73% | 52.88% | |
| EPS YoY % growth | -3.72 -965.12% | -4.15 -11.56% | -3.10 25.30% | -3.57 -15.04% | -4.13 -15.84% | -3.54 14.26% | -2.63 25.85% | -0.31 88.09% | 1.35 531.46% | 3.96 193.58% | 3.70 -6.56% | 4.82 30.30% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.07 -3.50% | -1.16 -2.00% | -1.18 | -1.05 17.60% | -1.04 2.21% | -0.98 15.53% | -0.97 18.13% | -0.87 17.25% | -0.80 23.48% | -0.52 46.83% | -0.32 67.09% | -0.20 77.27% |
| Revenue Q2Q % growth | 36.879M 41.84% | 24.569M -12.25% | 20.948M -86.91% | 31.199M 20.00% | 21.586M -41.47% | 30.173M 22.81% | 21.478M 2.53% | 38.356M 22.94% | 52.416M 142.82% | 106.13M 251.74% | 149.99M 598.34% | 178.76M 366.05% |
| EBITDA Q2Q % growth | -90.704M 2.47% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -125.358M -21.71% | -130.968M -7.35% | -137.853M -1,623.16% | -101.796M 28.31% | -109.803M 12.41% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -1.27 -27.00% | -1.34 | 0.07 | 4.95% |
| Q2 2025 Q2Q % growth | 0.00 100.00% | -1.15 | 1.15 | 100.00% |
| Q1 2025 Q2Q % growth | -1.14 -2,180.00% | -1.05 | -0.09 | -8.41% |
| Q4 2024 Q2Q % growth | -1.03 4.63% | -1.27 | 0.24 | 19.13% |
| Q3 2024 Q2Q % growth | -1.00 -6.38% | -1.08 | 0.08 | 7.78% |
| Q2 2024 Q2Q % growth | -1.02 1.92% | -1.12 | 0.10 | 8.92% |
| Q1 2024 Q2Q % growth | -0.05 95.41% | -0.97 | 0.92 | 94.85% |
| Q4 2023 Q2Q % growth | -1.08 -16.13% | -1.04 | -0.04 | -3.39% |
| Q3 2023 Q2Q % growth | -0.94 -4.44% | -1.15 | 0.21 | 18.35% |
| Q2 2023 Q2Q % growth | -1.04 -11.83% | -1.12 | 0.08 | 7.19% |
| Q1 2023 Q2Q % growth | -1.09 -13.54% | -1.19 | 0.10 | 8.14% |
| Q4 2022 Q2Q % growth | -0.93 -125.07% | -1.09 | 0.16 | 14.53% |
| Q3 2022 Q2Q % growth | -0.90 18.92% | -1.06 | 0.16 | 14.99% |
| Q2 2022 Q2Q % growth | -0.93 14.68% | -0.96 | 0.03 | 3.18% |
| Q1 2022 Q2Q % growth | -0.96 11.11% | -0.88 | -0.08 | -9.30% |
| Q4 2021 Q2Q % growth | 3.71 552.44% | -0.76 | 4.47 | 589.04% |
| Q3 2021 Q2Q % growth | -1.11 -3,800.00% | -1.10 | -0.01 | -1.15% |
| Q2 2021 Q2Q % growth | -1.09 -17.20% | -0.89 | -0.20 | -22.28% |
| Q1 2021 Q2Q % growth | -1.08 -71.43% | -0.84 | -0.24 | -27.86% |
| Q4 2020 Q2Q % growth | -0.82 | -0.76 | -0.06 | -7.29% |
| Q3 2020 Q2Q % growth | 0.03 | 0.05 | -0.02 | -41.18% |
| Q2 2020 Q2Q % growth | -0.93 | -0.62 | -0.31 | -49.04% |
| Q1 2020 Q2Q % growth | -0.63 | -0.58 | -0.05 | -9.44% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 26M -45.83% | 21.828M | 4.172M | 19.11% |
| Q2 2025 Q2Q % growth | 160M 310.26% | 32.176M | 127.824M | 397.27% |
| Q1 2025 Q2Q % growth | 28M -80.69% | 37.271M | -9.271M | -24.87% |
| Q4 2024 Q2Q % growth | 26M -16.13% | 29.478M | -3.478M | -11.80% |
| Q3 2024 Q2Q % growth | 48M 50.00% | 38.307M | 9.693M | 25.30% |
| Q2 2024 Q2Q % growth | 39M 34.48% | 26.125M | 12.875M | 49.28% |
| Q1 2024 Q2Q % growth | 145M 480.00% | 34.54M | 110.46M | 319.80% |
| Q4 2023 Q2Q % growth | 31M -8.01% | 28.935M | 2.065M | 7.14% |
| Q3 2023 Q2Q % growth | 32M -4.76% | 27.828M | 4.172M | 14.99% |
| Q2 2023 Q2Q % growth | 29M 8.21% | 30.904M | -1.904M | -6.16% |
| Q1 2023 Q2Q % growth | 25M 38.89% | 25.467M | -467K | -1.83% |
| Q4 2022 Q2Q % growth | 33.7M -90.49% | 23.773M | 9.927M | 41.76% |
| Q3 2022 Q2Q % growth | 33.6M 253.68% | 22.325M | 11.275M | 50.50% |
| Q2 2022 Q2Q % growth | 26.8M 182.11% | 21.548M | 5.252M | 24.37% |
| Q1 2022 Q2Q % growth | 18M 89.47% | 27.158M | -9.158M | -33.72% |
| Q4 2021 Q2Q % growth | 354.5M 3,631.58% | 40.175M | 314.325M | 782.39% |
| Q3 2021 Q2Q % growth | 9.5M -85.27% | 9.588M | -88K | -0.92% |
| Q2 2021 Q2Q % growth | 9.5M 427.78% | 13.316M | -3.816M | -28.66% |
| Q1 2021 Q2Q % growth | 9.5M 427.78% | 12.49M | -2.99M | -23.94% |
| Q4 2020 Q2Q % growth | 9.5M | 8.087M | 1.413M | 17.47% |
| Q3 2020 Q2Q % growth | 64.5M | 49.113M | 15.387M | 31.33% |
| Q2 2020 Q2Q % growth | 1.8M | 1.664M | 136K | 8.17% |
| Q1 2020 Q2Q % growth | 1.8M | 1.562M | 238K | 15.24% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.12% | 13.07% | 3.97% | 7.23% |
| Revenue | -5.91% | 65.39% | 3.5% | 6.46% |